Disc Medicine, Inc. (IRON)
64.63
-2.22
(-3.32%)
USD |
NASDAQ |
May 19, 13:35
Disc Medicine Research and Development Expense (Quarterly) : 45.82M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cytokinetics, Inc. | 92.15M |
| Regeneron Pharmaceuticals, Inc. | 1.420B |
| REGENXBIO, Inc. | 53.48M |
| Replimune Group, Inc. | 52.87M |
| Olema Pharmaceuticals, Inc. | 49.23M |